Literature DB >> 30538890

Volumetric trends of progressive in-field recurrences after stereotactic radiosurgery of metastatic intracranial tumors.

Purvee D Patel1, Eric L Hargreaves1, Adnan F Danish2, Joseph Weiner3, Shabbar F Danish1.   

Abstract

OBJECTIVE: Local recurrence after stereotactic radiosurgery for brain metastasis is a well-known problem. We analyzed volumetric trends from the time of radiosurgery to time of treatment to understand progression behavior.
METHODS: A retrospective review of patients who underwent treatment for post-radiation progressive lesions was performed. Volumetric trends were obtained by plotting individual lesion volumes from the post-radiation nadir volume to volume at treatment and then fitted to exponential decay or linear regressions.
RESULTS: Twenty-eight post-radiation recurrences demonstrated exponential growth and thirteen followed a linear pattern. For lesions exhibiting exponential growth, the average nadir volume was 0.26cm3 (SEM=0.06) at an average of 298 days before treatment and mean volume at treatment was 2.39cm3 (SEM=0.33). The average adjusted R2 was 0.94 (SEM=0.013) and doubling factor was 68.60days (SEM=12.55). In the linear growth cohort, the mean nadir volume was 1.43cm3 (SEM=0.25) at an average of 158 days before treatment and average volume at treatment was 6.90cm3 (SEM=1.43). The mean R2 was 0.92 (SEM=0.02) and average growth rate was 0.034cm3/day. Majority of lesions from primary non-small cell lung cancer (81%) and breast cancer (63%) followed exponential growth.
CONCLUSIONS: Exponential and linear regressions are accurate representations of post-radiation progression behavior and may be valuable in understanding the growth patterns for recurrences ultimately requiring treatment.

Entities:  

Keywords:  progressive in-field recurrence; stereotactic radiosurgery

Year:  2018        PMID: 30538890      PMCID: PMC6255718     

Source DB:  PubMed          Journal:  J Radiosurg SBRT


  29 in total

1.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

2.  A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases.

Authors:  May Tsao; Wei Xu; Arjun Sahgal
Journal:  Cancer       Date:  2011-09-01       Impact factor: 6.860

3.  Is Gompertzian or exponential kinetics a valid description of individual human cancer growth?

Authors:  M W Retsky; D E Swartzendruber; R H Wardwell; P D Bame
Journal:  Med Hypotheses       Date:  1990-10       Impact factor: 1.538

4.  Three or More Courses of Stereotactic Radiosurgery for Patients with Multiply Recurrent Brain Metastases.

Authors:  Rupesh Kotecha; Nicholas Damico; Jacob A Miller; John H Suh; Erin S Murphy; Chandana A Reddy; Gene H Barnett; Michael A Vogelbaum; Lilyana Angelov; Alireza M Mohammadi; Samuel T Chao
Journal:  Neurosurgery       Date:  2017-06-01       Impact factor: 4.654

5.  Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.

Authors:  Will H McKay; Emory R McTyre; Catherine Okoukoni; Natalie K Alphonse-Sullivan; Jimmy Ruiz; Michael T Munley; Shadi Qasem; Hui-Wen Lo; Fei Xing; Adrian W Laxton; Stephen B Tatter; Kounosuke Watabe; Michael D Chan
Journal:  J Neurosurg       Date:  2016-08-05       Impact factor: 5.115

6.  Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Rikiya Onimaru; Kenji Kagei; Jun Ikeda; Nobuaki Ishii; Yutaka Sawamura; Kazuo Miyasaka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-01       Impact factor: 7.038

7.  Local control after fractionated stereotactic radiation therapy for brain metastases.

Authors:  Selvan Rajakesari; Nils D Arvold; Rachel B Jimenez; Laura W Christianson; Margaret C Horvath; Elizabeth B Claus; Alexandra J Golby; Mark D Johnson; Ian F Dunn; Eudocia Q Lee; Nancy U Lin; Scott Friesen; Edward G Mannarino; Matthew Wagar; Fred L Hacker; Stephanie E Weiss; Brian M Alexander
Journal:  J Neurooncol       Date:  2014-07-25       Impact factor: 4.130

8.  Real-time magnetic resonance-guided laser thermal therapy for focal metastatic brain tumors.

Authors:  Alexandre Carpentier; Roger J McNichols; R Jason Stafford; Julian Itzcovitz; Jean-Pierre Guichard; Daniel Reizine; Suzette Delaloge; Eric Vicaut; Didier Payen; Ashok Gowda; Bernard George
Journal:  Neurosurgery       Date:  2008-07       Impact factor: 4.654

9.  Quantitative analysis of tumor growth rate and changes in tumor marker level: specific growth rate versus doubling time.

Authors:  Esmaeil Mehrara; Eva Forssell-Aronsson; Håkan Ahlman; Peter Bernhardt
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

10.  Classical mathematical models for description and prediction of experimental tumor growth.

Authors:  Sébastien Benzekry; Clare Lamont; Afshin Beheshti; Amanda Tracz; John M L Ebos; Lynn Hlatky; Philip Hahnfeldt
Journal:  PLoS Comput Biol       Date:  2014-08-28       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.